MedPath

Predictors of Sepsis - Pred Sep

Conditions
I63.5
A41
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
Other sepsis
Registration Number
DRKS00003392
Lead Sponsor
Klinik für Neurologie
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
287
Inclusion Criteria

Ischemic infarction in the territory of the middle cerebral artery.
Age = 18.
NIH stroke score NIHSS > 8.

Exclusion Criteria

Existing infections at admission.
History of previous strokes.
Cardiogenic arrhythmias.

Study & Design

Study Type
observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Development of infection within the subacute phase (day 1-5) of the stroke.<br>Infection is defined according to the PANTHERIS study:<br>- Pneumonia is defined as presence of at least one of the A and one of the B criteria: A) abnormal respiratory examination, pulmonary infiltrates in chest X-Ray; B) productive cough with purulent sputum, microbiological cultures from lower respiratory tract or blood cultures, leukocytosis, and elevation of C-reactive protein (CRP). <br>- Urinary tract infection is defined as the presence of two of the following criteria: fever (>38.0 °C), urine sample positive for nitrite, leucocyturia, and significant bacteriuria.<br>- Infection is also diagnosed if temperature is above 38.0°C on at least 2 determinations with additional leucocytosis and positive blood cultures, but no determined focus. <br>
Secondary Outcome Measures
NameTimeMethod
Development of SIRS and severe sepsis in the subacute phase (day 1-5) after Stroke and functional outcome after 3 months.<br>-SIRS (criteria I) is defined according to Guidelines of the German Sepsis Society<br>-Severe Sepsis (criteria I, II and III) is defined according to Guidelines of the German Sepsis Society.<br>- Functional outcome is measured by lethality and neurological scores (modified Rankin Scale, Barthel Index, NIHSS).<br>
© Copyright 2025. All Rights Reserved by MedPath